

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.30614901 |
| 2 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 4.42914016 |
| 3 | protein localization to endosome (GO:0036010) | 4.33004713 |
| 4 | regulation of vitamin metabolic process (GO:0030656) | 4.24568357 |
| 5 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 4.15571279 |
| 6 | nuclear pore complex assembly (GO:0051292) | 4.05747005 |
| 7 | cysteine metabolic process (GO:0006534) | 4.05229604 |
| 8 | regulation of mononuclear cell migration (GO:0071675) | 3.94381840 |
| 9 | negative regulation of fibrinolysis (GO:0051918) | 3.91667991 |
| 10 | urea cycle (GO:0000050) | 3.85345449 |
| 11 | urea metabolic process (GO:0019627) | 3.85345449 |
| 12 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.80414439 |
| 13 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.79449494 |
| 14 | protein carboxylation (GO:0018214) | 3.79449494 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 3.73563753 |
| 16 | response to peptidoglycan (GO:0032494) | 3.72798969 |
| 17 | glycine metabolic process (GO:0006544) | 3.71462879 |
| 18 | nuclear pore organization (GO:0006999) | 3.69699002 |
| 19 | oligosaccharide catabolic process (GO:0009313) | 3.69402790 |
| 20 | serine family amino acid catabolic process (GO:0009071) | 3.64870016 |
| 21 | regulation of cholesterol homeostasis (GO:2000188) | 3.62814666 |
| 22 | glycosphingolipid catabolic process (GO:0046479) | 3.58925694 |
| 23 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.57208313 |
| 24 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.51113202 |
| 25 | L-phenylalanine catabolic process (GO:0006559) | 3.51113202 |
| 26 | homocysteine metabolic process (GO:0050667) | 3.46982615 |
| 27 | lysine catabolic process (GO:0006554) | 3.46196126 |
| 28 | lysine metabolic process (GO:0006553) | 3.46196126 |
| 29 | regulation of protein activation cascade (GO:2000257) | 3.45363941 |
| 30 | skin morphogenesis (GO:0043589) | 3.41682621 |
| 31 | negative regulation of interleukin-12 production (GO:0032695) | 3.41388497 |
| 32 | sulfur amino acid catabolic process (GO:0000098) | 3.41059174 |
| 33 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.39511664 |
| 34 | L-phenylalanine metabolic process (GO:0006558) | 3.39511664 |
| 35 | kynurenine metabolic process (GO:0070189) | 3.39149323 |
| 36 | regulation of fever generation (GO:0031620) | 3.36141727 |
| 37 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.34157744 |
| 38 | complement activation, alternative pathway (GO:0006957) | 3.33380365 |
| 39 | aromatic amino acid family catabolic process (GO:0009074) | 3.32412716 |
| 40 | nitrogen cycle metabolic process (GO:0071941) | 3.31603672 |
| 41 | regulation of fibrinolysis (GO:0051917) | 3.30259117 |
| 42 | COPI coating of Golgi vesicle (GO:0048205) | 3.29369769 |
| 43 | Golgi transport vesicle coating (GO:0048200) | 3.29369769 |
| 44 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.28971921 |
| 45 | regulation of complement activation (GO:0030449) | 3.28864787 |
| 46 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.28246843 |
| 47 | epoxygenase P450 pathway (GO:0019373) | 3.27061471 |
| 48 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.24971308 |
| 49 | positive regulation of heat generation (GO:0031652) | 3.23604084 |
| 50 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.22770468 |
| 51 | serine family amino acid metabolic process (GO:0009069) | 3.21261156 |
| 52 | hypotonic response (GO:0006971) | 3.20429689 |
| 53 | glycolipid catabolic process (GO:0019377) | 3.19847793 |
| 54 | negative regulation of cholesterol transport (GO:0032375) | 3.17297316 |
| 55 | negative regulation of sterol transport (GO:0032372) | 3.17297316 |
| 56 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.13783751 |
| 57 | tryptophan catabolic process (GO:0006569) | 3.13364393 |
| 58 | indole-containing compound catabolic process (GO:0042436) | 3.13364393 |
| 59 | indolalkylamine catabolic process (GO:0046218) | 3.13364393 |
| 60 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.08318430 |
| 61 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.07836583 |
| 62 | tryptophan metabolic process (GO:0006568) | 3.06271012 |
| 63 | regulation of vascular endothelial growth factor production (GO:0010574) | 3.05400045 |
| 64 | mitotic sister chromatid cohesion (GO:0007064) | 3.02547175 |
| 65 | apoptotic cell clearance (GO:0043277) | 2.99577691 |
| 66 | glyoxylate metabolic process (GO:0046487) | 2.97517593 |
| 67 | bile acid biosynthetic process (GO:0006699) | 2.96790403 |
| 68 | serine family amino acid biosynthetic process (GO:0009070) | 2.94510256 |
| 69 | pore complex assembly (GO:0046931) | 2.93009669 |
| 70 | wound healing, spreading of epidermal cells (GO:0035313) | 2.92815677 |
| 71 | high-density lipoprotein particle remodeling (GO:0034375) | 2.91673642 |
| 72 | phospholipid homeostasis (GO:0055091) | 2.90280339 |
| 73 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.90274147 |
| 74 | positive regulation of extracellular matrix organization (GO:1903055) | 2.89871081 |
| 75 | one-carbon metabolic process (GO:0006730) | 2.89460587 |
| 76 | regulation of early endosome to late endosome transport (GO:2000641) | 2.87807641 |
| 77 | low-density lipoprotein particle clearance (GO:0034383) | 2.86161304 |
| 78 | negative regulation of lipid storage (GO:0010888) | 2.85343807 |
| 79 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.84858940 |
| 80 | endodermal cell differentiation (GO:0035987) | 2.84122591 |
| 81 | osteoclast differentiation (GO:0030316) | 2.83534175 |
| 82 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.83501057 |
| 83 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.83305379 |
| 84 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.82145363 |
| 85 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.82136979 |
| 86 | regulation of chemokine biosynthetic process (GO:0045073) | 2.82080645 |
| 87 | amino-acid betaine metabolic process (GO:0006577) | 2.80913289 |
| 88 | epithelial cell-cell adhesion (GO:0090136) | 2.80521198 |
| 89 | response to laminar fluid shear stress (GO:0034616) | 2.79950162 |
| 90 | valine metabolic process (GO:0006573) | 2.78275660 |
| 91 | negative regulation of lipid transport (GO:0032369) | 2.77589901 |
| 92 | folic acid metabolic process (GO:0046655) | 2.77335753 |
| 93 | decidualization (GO:0046697) | 2.77314181 |
| 94 | cell adhesion mediated by integrin (GO:0033627) | 2.75209019 |
| 95 | regulation of RNA export from nucleus (GO:0046831) | 2.75175608 |
| 96 | response to thyroid hormone (GO:0097066) | 2.75131976 |
| 97 | substrate-dependent cell migration (GO:0006929) | 2.74143243 |
| 98 | bile acid metabolic process (GO:0008206) | 2.74124809 |
| 99 | plasma lipoprotein particle clearance (GO:0034381) | 2.73471672 |
| 100 | regulation of podosome assembly (GO:0071801) | 2.73284376 |
| 101 | regulation of triglyceride catabolic process (GO:0010896) | 2.72003669 |
| 102 | pinocytosis (GO:0006907) | 2.70078960 |
| 103 | regulation of macrophage chemotaxis (GO:0010758) | 2.69256603 |
| 104 | 2-oxoglutarate metabolic process (GO:0006103) | 2.68776572 |
| 105 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.68690362 |
| 106 | positive regulation of lipid catabolic process (GO:0050996) | 2.68460869 |
| 107 | cellular response to ethanol (GO:0071361) | 2.68072596 |
| 108 | growth hormone receptor signaling pathway (GO:0060396) | 2.67892406 |
| 109 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.67379865 |
| 110 | embryonic process involved in female pregnancy (GO:0060136) | 2.67365656 |
| 111 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.66804441 |
| 112 | bile acid and bile salt transport (GO:0015721) | 2.66400564 |
| 113 | reverse cholesterol transport (GO:0043691) | 2.65581484 |
| 114 | tetrahydrofolate metabolic process (GO:0046653) | 2.65550624 |
| 115 | hyaluronan catabolic process (GO:0030214) | 2.65535839 |
| 116 | regulation of cholesterol storage (GO:0010885) | 2.65320053 |
| 117 | NLS-bearing protein import into nucleus (GO:0006607) | 2.64805345 |
| 118 | triglyceride homeostasis (GO:0070328) | 2.64517788 |
| 119 | acylglycerol homeostasis (GO:0055090) | 2.64517788 |
| 120 | ceramide catabolic process (GO:0046514) | 2.64514530 |
| 121 | protein-lipid complex assembly (GO:0065005) | 2.64282108 |
| 122 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.63061834 |
| 123 | regulation of translational termination (GO:0006449) | 2.62988561 |
| 124 | regulation of integrin activation (GO:0033623) | 2.62195149 |
| 125 | cellular response to arsenic-containing substance (GO:0071243) | 2.62075910 |
| 126 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.60604907 |
| 127 | ethanol oxidation (GO:0006069) | 2.60566105 |
| 128 | stress fiber assembly (GO:0043149) | 2.60300990 |
| 129 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.59958883 |
| 130 | fibrinolysis (GO:0042730) | 2.58402958 |
| 131 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.57922741 |
| 132 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.57169141 |
| 133 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.56507348 |
| 134 | plasma lipoprotein particle assembly (GO:0034377) | 2.56437178 |
| 135 | lipoprotein metabolic process (GO:0042157) | 2.55465398 |
| 136 | 4-hydroxyproline metabolic process (GO:0019471) | 2.54911203 |
| 137 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.53515621 |
| 138 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.51629355 |
| 139 | negative regulation of fatty acid transport (GO:2000192) | 2.49388337 |
| 140 | detection of molecule of bacterial origin (GO:0032490) | 2.48541549 |
| 141 | sterol homeostasis (GO:0055092) | 2.48331600 |
| 142 | mRNA transcription (GO:0009299) | 2.48162843 |
| 143 | cellular glucuronidation (GO:0052695) | 2.47916970 |
| 144 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.47832088 |
| 145 | negative regulation of anoikis (GO:2000811) | 2.47740006 |
| 146 | tyrosine metabolic process (GO:0006570) | 2.47691543 |
| 147 | fatty acid transmembrane transport (GO:1902001) | 2.46197900 |
| 148 | regulation of translational fidelity (GO:0006450) | 2.46067855 |
| 149 | COPII vesicle coating (GO:0048208) | 2.45996548 |
| 150 | membrane lipid catabolic process (GO:0046466) | 2.45227451 |
| 151 | alpha-amino acid catabolic process (GO:1901606) | 2.45153199 |
| 152 | regulation of spindle organization (GO:0090224) | 2.45146021 |
| 153 | mammary gland epithelial cell proliferation (GO:0033598) | 2.44647033 |
| 154 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.44635732 |
| 155 | positive regulation of histone deacetylation (GO:0031065) | 2.44487091 |
| 156 | iron ion import (GO:0097286) | 2.44174284 |
| 157 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.44085010 |
| 158 | glutamate metabolic process (GO:0006536) | 2.43869394 |
| 159 | cholesterol homeostasis (GO:0042632) | 2.43360705 |
| 160 | barbed-end actin filament capping (GO:0051016) | 2.42660371 |
| 161 | protein localization to kinetochore (GO:0034501) | 2.42165139 |
| 162 | sphingosine metabolic process (GO:0006670) | 2.41387568 |
| 163 | plasma lipoprotein particle remodeling (GO:0034369) | 2.41280790 |
| 164 | protein-lipid complex remodeling (GO:0034368) | 2.41280790 |
| 165 | macromolecular complex remodeling (GO:0034367) | 2.41280790 |
| 166 | mesodermal cell differentiation (GO:0048333) | 2.41271108 |
| 167 | aromatic amino acid family metabolic process (GO:0009072) | 2.41118083 |
| 168 | urate metabolic process (GO:0046415) | 2.40668702 |
| 169 | cellular response to lipopolysaccharide (GO:0071222) | 2.40212801 |
| 170 | organ regeneration (GO:0031100) | 2.40193124 |
| 171 | monocyte chemotaxis (GO:0002548) | 2.39775865 |
| 172 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.38421871 |
| 173 | membrane protein ectodomain proteolysis (GO:0006509) | 2.38244217 |
| 174 | hemidesmosome assembly (GO:0031581) | 2.37904418 |
| 175 | positive regulation of leukocyte degranulation (GO:0043302) | 2.37707936 |
| 176 | cell-substrate junction assembly (GO:0007044) | 2.36667542 |
| 177 | cortical actin cytoskeleton organization (GO:0030866) | 2.34539511 |
| 178 | negative regulation of alcohol biosynthetic process (GO:1902931) | 2.33053368 |
| 179 | eosinophil chemotaxis (GO:0048245) | 2.32600974 |
| 180 | positive regulation of interleukin-6 production (GO:0032755) | 2.31270903 |
| 181 | response to vitamin D (GO:0033280) | 2.30655927 |
| 182 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.30336769 |
| 183 | chronic inflammatory response (GO:0002544) | 2.29103264 |
| 184 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.29081824 |
| 185 | membrane raft organization (GO:0031579) | 2.28689660 |
| 186 | germinal center formation (GO:0002467) | 2.28601837 |
| 187 | hyaluronan metabolic process (GO:0030212) | 2.27917578 |
| 188 | glial cell migration (GO:0008347) | 2.26738296 |
| 189 | cellular response to molecule of bacterial origin (GO:0071219) | 2.25367901 |
| 190 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.25268366 |
| 191 | wound healing, spreading of cells (GO:0044319) | 2.24594461 |
| 192 | response to lipoprotein particle (GO:0055094) | 2.21327414 |
| 193 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.17803856 |
| 194 | positive regulation of leukocyte chemotaxis (GO:0002690) | 2.17126875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.42438875 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.32051517 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.94869978 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.73501529 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.70475369 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.67862926 |
| 7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.60406632 |
| 8 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.27962016 |
| 9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.09727096 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.75742559 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.70873761 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.59292141 |
| 13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.59234394 |
| 14 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.42839663 |
| 15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.42150880 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.39012691 |
| 17 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.31661786 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.27439758 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.09041037 |
| 20 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.07737460 |
| 21 | MYC_22102868_ChIP-Seq_BL_Human | 2.01678764 |
| 22 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.95400899 |
| 23 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.93119317 |
| 24 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.85977366 |
| 25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.80932217 |
| 26 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.80916356 |
| 27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.79952796 |
| 28 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.75751638 |
| 29 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.68277464 |
| 30 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.65261331 |
| 31 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.65131509 |
| 32 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.63153276 |
| 33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.63074723 |
| 34 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.58203313 |
| 35 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.56372282 |
| 36 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.52449983 |
| 37 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.51645377 |
| 38 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.49767127 |
| 39 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.49693993 |
| 40 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.47103970 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.46865947 |
| 42 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.43103606 |
| 43 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.42016796 |
| 44 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.41982325 |
| 45 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.41955411 |
| 46 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.41856218 |
| 47 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.41818857 |
| 48 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.40835798 |
| 49 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.40676898 |
| 50 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39889153 |
| 51 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.39603606 |
| 52 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.39406091 |
| 53 | ATF3_27146783_Chip-Seq_COLON_Human | 1.38944600 |
| 54 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37536695 |
| 55 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.37367646 |
| 56 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.37221064 |
| 57 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.37169139 |
| 58 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.36961049 |
| 59 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34483600 |
| 60 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.34265875 |
| 61 | CJUN_26792858_Chip-Seq_BT549_Human | 1.34108386 |
| 62 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33729029 |
| 63 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.31828494 |
| 64 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.31066807 |
| 65 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.29789641 |
| 66 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.29392232 |
| 67 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.28945139 |
| 68 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.28843858 |
| 69 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.28512328 |
| 70 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28163354 |
| 71 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.27721050 |
| 72 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.27539266 |
| 73 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.26905701 |
| 74 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.26364995 |
| 75 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.25243634 |
| 76 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.25243634 |
| 77 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.24237834 |
| 78 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.23831448 |
| 79 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22347990 |
| 80 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20976271 |
| 81 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.20832090 |
| 82 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.19795416 |
| 83 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.19795416 |
| 84 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.18693606 |
| 85 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.17612112 |
| 86 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16333127 |
| 87 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.15876416 |
| 88 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.15860319 |
| 89 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.15522362 |
| 90 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.14808295 |
| 91 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.14438202 |
| 92 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.13854066 |
| 93 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12533741 |
| 94 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.12240216 |
| 95 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.11558765 |
| 96 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.09168640 |
| 97 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.09089334 |
| 98 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.09089334 |
| 99 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.08000627 |
| 100 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.07368310 |
| 101 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.06931076 |
| 102 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06136238 |
| 103 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.05742580 |
| 104 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.03046003 |
| 105 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.01485514 |
| 106 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.01098417 |
| 107 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.01090354 |
| 108 | SPI1_23127762_ChIP-Seq_K562_Human | 1.00707414 |
| 109 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.00001422 |
| 110 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.98060575 |
| 111 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97871080 |
| 112 | MYB_26560356_Chip-Seq_TH1_Human | 0.97826974 |
| 113 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.97091397 |
| 114 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.96659460 |
| 115 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.96470823 |
| 116 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95026609 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94803001 |
| 118 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.94631626 |
| 119 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94539131 |
| 120 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94281620 |
| 121 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.94067251 |
| 122 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.92495586 |
| 123 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.92198302 |
| 124 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.91574645 |
| 125 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.91564676 |
| 126 | MAF_26560356_Chip-Seq_TH1_Human | 0.91251433 |
| 127 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.91063149 |
| 128 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88454112 |
| 129 | UTX_26944678_Chip-Seq_JUKART_Human | 0.87594038 |
| 130 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.87433399 |
| 131 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.87185365 |
| 132 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.86253676 |
| 133 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86132384 |
| 134 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.85287331 |
| 135 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.85004845 |
| 136 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.84626995 |
| 137 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.83776121 |
| 138 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.83391155 |
| 139 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.82762443 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.63443392 |
| 2 | MP0005360_urolithiasis | 4.01853491 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.61969995 |
| 4 | MP0005365_abnormal_bile_salt | 3.40373220 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.29870984 |
| 6 | MP0010352_gastrointestinal_tract_polyps | 2.83327495 |
| 7 | MP0003252_abnormal_bile_duct | 2.82269944 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 2.42121509 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.39793084 |
| 10 | MP0005451_abnormal_body_composition | 2.37916955 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.37601278 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.36548345 |
| 13 | MP0005076_abnormal_cell_differentiation | 2.10659315 |
| 14 | MP0003950_abnormal_plasma_membrane | 2.07341631 |
| 15 | MP0004510_myositis | 2.07163920 |
| 16 | MP0010329_abnormal_lipoprotein_level | 1.99766487 |
| 17 | MP0009840_abnormal_foam_cell | 1.91993425 |
| 18 | MP0000343_altered_response_to | 1.87252521 |
| 19 | MP0002254_reproductive_system_inflammat | 1.86263392 |
| 20 | MP0003806_abnormal_nucleotide_metabolis | 1.83829673 |
| 21 | MP0005257_abnormal_intraocular_pressure | 1.77995720 |
| 22 | MP0006082_CNS_inflammation | 1.76656403 |
| 23 | MP0010307_abnormal_tumor_latency | 1.75729604 |
| 24 | MP0008438_abnormal_cutaneous_collagen | 1.74397178 |
| 25 | MP0003566_abnormal_cell_adhesion | 1.73228824 |
| 26 | MP0003448_altered_tumor_morphology | 1.67568367 |
| 27 | MP0002998_abnormal_bone_remodeling | 1.65475299 |
| 28 | MP0000609_abnormal_liver_physiology | 1.65377308 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 1.63646760 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.61048132 |
| 31 | MP0001666_abnormal_nutrient_absorption | 1.61032148 |
| 32 | MP0008004_abnormal_stomach_pH | 1.60765052 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.56982155 |
| 34 | MP0005083_abnormal_biliary_tract | 1.54301372 |
| 35 | MP0004233_abnormal_muscle_weight | 1.51860531 |
| 36 | MP0002877_abnormal_melanocyte_morpholog | 1.50190610 |
| 37 | MP0000858_altered_metastatic_potential | 1.49030512 |
| 38 | MP0003941_abnormal_skin_development | 1.48376528 |
| 39 | MP0000604_amyloidosis | 1.44889961 |
| 40 | MP0009053_abnormal_anal_canal | 1.42672046 |
| 41 | MP0003172_abnormal_lysosome_physiology | 1.41460939 |
| 42 | MP0004185_abnormal_adipocyte_glucose | 1.39449359 |
| 43 | MP0002166_altered_tumor_susceptibility | 1.38361027 |
| 44 | MP0005164_abnormal_response_to | 1.35892230 |
| 45 | MP0002419_abnormal_innate_immunity | 1.35460543 |
| 46 | MP0005023_abnormal_wound_healing | 1.33924818 |
| 47 | MP0009785_altered_susceptibility_to | 1.33139731 |
| 48 | MP0003075_altered_response_to | 1.30774431 |
| 49 | MP0003279_aneurysm | 1.30563412 |
| 50 | MP0003828_pulmonary_edema | 1.30004219 |
| 51 | MP0004264_abnormal_extraembryonic_tissu | 1.29417825 |
| 52 | MP0000733_abnormal_muscle_development | 1.26210696 |
| 53 | MP0005332_abnormal_amino_acid | 1.24644344 |
| 54 | MP0003868_abnormal_feces_composition | 1.24143084 |
| 55 | MP0009764_decreased_sensitivity_to | 1.20974908 |
| 56 | MP0001533_abnormal_skeleton_physiology | 1.19275169 |
| 57 | MP0001853_heart_inflammation | 1.19171198 |
| 58 | MP0001730_embryonic_growth_arrest | 1.18649945 |
| 59 | MP0009384_cardiac_valve_regurgitation | 1.18550228 |
| 60 | MP0002086_abnormal_extraembryonic_tissu | 1.18403267 |
| 61 | MP0004197_abnormal_fetal_growth/weight/ | 1.15181292 |
| 62 | MP0001915_intracranial_hemorrhage | 1.09649099 |
| 63 | MP0002118_abnormal_lipid_homeostasis | 1.09427500 |
| 64 | MP0002088_abnormal_embryonic_growth/wei | 1.08231552 |
| 65 | MP0000598_abnormal_liver_morphology | 1.08142888 |
| 66 | MP0003984_embryonic_growth_retardation | 1.07876630 |
| 67 | MP0005275_abnormal_skin_tensile | 1.07116100 |
| 68 | MP0005623_abnormal_meninges_morphology | 1.06402816 |
| 69 | MP0005666_abnormal_adipose_tissue | 1.05596664 |
| 70 | MP0005319_abnormal_enzyme/_coenzyme | 1.05541372 |
| 71 | MP0003453_abnormal_keratinocyte_physiol | 1.04759589 |
| 72 | MP0003693_abnormal_embryo_hatching | 1.04539937 |
| 73 | MP0005000_abnormal_immune_tolerance | 1.04408968 |
| 74 | MP0005380_embryogenesis_phenotype | 1.04310408 |
| 75 | MP0001672_abnormal_embryogenesis/_devel | 1.04310408 |
| 76 | MP0002332_abnormal_exercise_endurance | 1.04143090 |
| 77 | MP0003091_abnormal_cell_migration | 1.04080647 |
| 78 | MP0006054_spinal_hemorrhage | 1.03489441 |
| 79 | MP0000371_diluted_coat_color | 1.02808863 |
| 80 | MP0004957_abnormal_blastocyst_morpholog | 1.00650781 |
| 81 | MP0002006_tumorigenesis | 0.99839184 |
| 82 | MP0008057_abnormal_DNA_replication | 0.98833424 |
| 83 | MP0005397_hematopoietic_system_phenotyp | 0.97647796 |
| 84 | MP0001545_abnormal_hematopoietic_system | 0.97647796 |
| 85 | MP0003690_abnormal_glial_cell | 0.97220766 |
| 86 | MP0003111_abnormal_nucleus_morphology | 0.97134033 |
| 87 | MP0002060_abnormal_skin_morphology | 0.96704261 |
| 88 | MP0001216_abnormal_epidermal_layer | 0.95843064 |
| 89 | MP0003221_abnormal_cardiomyocyte_apopto | 0.95128131 |
| 90 | MP0005166_decreased_susceptibility_to | 0.94923742 |
| 91 | MP0001881_abnormal_mammary_gland | 0.94837606 |
| 92 | MP0000350_abnormal_cell_proliferation | 0.93516677 |
| 93 | MP0009672_abnormal_birth_weight | 0.93253090 |
| 94 | MP0003303_peritoneal_inflammation | 0.93194238 |
| 95 | MP0003724_increased_susceptibility_to | 0.92632481 |
| 96 | MP0010678_abnormal_skin_adnexa | 0.92356438 |
| 97 | MP0001835_abnormal_antigen_presentation | 0.92280637 |
| 98 | MP0004019_abnormal_vitamin_homeostasis | 0.91419295 |
| 99 | MP0005220_abnormal_exocrine_pancreas | 0.91365759 |
| 100 | MP0001849_ear_inflammation | 0.90738094 |
| 101 | MP0001958_emphysema | 0.90147479 |
| 102 | MP0004272_abnormal_basement_membrane | 0.89973421 |
| 103 | MP0005165_increased_susceptibility_to | 0.89482827 |
| 104 | MP0004808_abnormal_hematopoietic_stem | 0.89327516 |
| 105 | MP0000627_abnormal_mammary_gland | 0.87386765 |
| 106 | MP0002396_abnormal_hematopoietic_system | 0.87125445 |
| 107 | MP0004947_skin_inflammation | 0.87117071 |
| 108 | MP0005464_abnormal_platelet_physiology | 0.86776122 |
| 109 | MP0001790_abnormal_immune_system | 0.85776807 |
| 110 | MP0005387_immune_system_phenotype | 0.85776807 |
| 111 | MP0004130_abnormal_muscle_cell | 0.84007756 |
| 112 | MP0005248_abnormal_Harderian_gland | 0.82505102 |
| 113 | MP0003077_abnormal_cell_cycle | 0.82491787 |
| 114 | MP0010155_abnormal_intestine_physiology | 0.82369212 |
| 115 | MP0002405_respiratory_system_inflammati | 0.82336977 |
| 116 | MP0002928_abnormal_bile_duct | 0.81753131 |
| 117 | MP0001845_abnormal_inflammatory_respons | 0.81750751 |
| 118 | MP0000537_abnormal_urethra_morphology | 0.81326157 |
| 119 | MP0002452_abnormal_antigen_presenting | 0.81260924 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.80907171 |
| 121 | MP0005408_hypopigmentation | 0.80456993 |
| 122 | MP0009643_abnormal_urine_homeostasis | 0.80288232 |
| 123 | MP0005025_abnormal_response_to | 0.78761766 |
| 124 | MP0005310_abnormal_salivary_gland | 0.78282195 |
| 125 | MP0002084_abnormal_developmental_patter | 0.78158095 |
| 126 | MP0001697_abnormal_embryo_size | 0.78026856 |
| 127 | MP0003656_abnormal_erythrocyte_physiolo | 0.77139846 |
| 128 | MP0005621_abnormal_cell_physiology | 0.76911578 |
| 129 | MP0009278_abnormal_bone_marrow | 0.76477598 |
| 130 | MP0005375_adipose_tissue_phenotype | 0.76146074 |
| 131 | MP0008469_abnormal_protein_level | 0.75855569 |
| 132 | MP0000383_abnormal_hair_follicle | 0.75255532 |
| 133 | MP0010094_abnormal_chromosome_stability | 0.74464959 |
| 134 | MP0003795_abnormal_bone_structure | 0.74266581 |
| 135 | MP0004084_abnormal_cardiac_muscle | 0.72736391 |
| 136 | MP0002971_abnormal_brown_adipose | 0.72724745 |
| 137 | MP0009703_decreased_birth_body | 0.71719067 |
| 138 | MP0005197_abnormal_uvea_morphology | 0.71444527 |
| 139 | MP0003567_abnormal_fetal_cardiomyocyte | 0.70450330 |
| 140 | MP0003329_amyloid_beta_deposits | 0.70347437 |
| 141 | MP0002796_impaired_skin_barrier | 0.70032428 |
| 142 | MP0003115_abnormal_respiratory_system | 0.69154853 |
| 143 | MP0002168_other_aberrant_phenotype | 0.68906218 |
| 144 | MP0002080_prenatal_lethality | 0.68712298 |
| 145 | MP0000249_abnormal_blood_vessel | 0.68120113 |
| 146 | MP0001661_extended_life_span | 0.68095499 |
| 147 | MP0001727_abnormal_embryo_implantation | 0.68092673 |
| 148 | MP0003890_abnormal_embryonic-extraembry | 0.67617057 |
| 149 | MP0005647_abnormal_sex_gland | 0.67315408 |
| 150 | MP0003045_fibrosis | 0.67107753 |
| 151 | MP0003436_decreased_susceptibility_to | 0.66421041 |
| 152 | MP0000685_abnormal_immune_system | 0.66182968 |
| 153 | MP0000767_abnormal_smooth_muscle | 0.65783763 |
| 154 | MP0009763_increased_sensitivity_to | 0.65753695 |
| 155 | MP0008961_abnormal_basal_metabolism | 0.65242958 |
| 156 | MP0002092_abnormal_eye_morphology | 0.65092267 |
| 157 | MP0003195_calcinosis | 0.64973173 |
| 158 | MP0000569_abnormal_digit_pigmentation | 0.64734225 |
| 159 | MP0001243_abnormal_dermal_layer | 0.64726567 |
| 160 | MP0002896_abnormal_bone_mineralization | 0.63993197 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 4.87991830 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.87991830 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.87991830 |
| 4 | Deep venous thrombosis (HP:0002625) | 4.66682061 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.03223208 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.89862328 |
| 7 | Xanthomatosis (HP:0000991) | 3.58381939 |
| 8 | Myocardial infarction (HP:0001658) | 3.45647959 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 3.21676504 |
| 10 | Vacuolated lymphocytes (HP:0001922) | 3.05275481 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 2.98682295 |
| 12 | Complement deficiency (HP:0004431) | 2.97584146 |
| 13 | Spondylolisthesis (HP:0003302) | 2.92013509 |
| 14 | Dysostosis multiplex (HP:0000943) | 2.89319431 |
| 15 | Vertebral compression fractures (HP:0002953) | 2.85442122 |
| 16 | Epidermoid cyst (HP:0200040) | 2.84538456 |
| 17 | Osteolytic defects of the hand bones (HP:0009699) | 2.74374932 |
| 18 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.74374932 |
| 19 | Spastic diplegia (HP:0001264) | 2.73657033 |
| 20 | Hypolipoproteinemia (HP:0010981) | 2.72992416 |
| 21 | Increased cerebral lipofuscin (HP:0011813) | 2.69132983 |
| 22 | Esophageal varix (HP:0002040) | 2.68763075 |
| 23 | Tetraparesis (HP:0002273) | 2.68427665 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.67220017 |
| 25 | Neurofibrillary tangles (HP:0002185) | 2.66375057 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 2.64734398 |
| 27 | Arterial tortuosity (HP:0005116) | 2.61107638 |
| 28 | Loss of speech (HP:0002371) | 2.59133135 |
| 29 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.57984586 |
| 30 | Cerebral aneurysm (HP:0004944) | 2.56593654 |
| 31 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.56016413 |
| 32 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.53867103 |
| 33 | Mucopolysacchariduria (HP:0008155) | 2.53867103 |
| 34 | Hyperglycinemia (HP:0002154) | 2.53103685 |
| 35 | Increased mean platelet volume (HP:0011877) | 2.51346992 |
| 36 | Thin bony cortex (HP:0002753) | 2.49889151 |
| 37 | Subacute progressive viral hepatitis (HP:0006572) | 2.47485136 |
| 38 | Short nail (HP:0001799) | 2.46645946 |
| 39 | Spinal cord lesions (HP:0100561) | 2.46189956 |
| 40 | Syringomyelia (HP:0003396) | 2.46189956 |
| 41 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.46149577 |
| 42 | Cerebral inclusion bodies (HP:0100314) | 2.46009406 |
| 43 | Hyperlipoproteinemia (HP:0010980) | 2.44508054 |
| 44 | Hepatocellular carcinoma (HP:0001402) | 2.43944094 |
| 45 | Prolonged partial thromboplastin time (HP:0003645) | 2.42242476 |
| 46 | Abnormality of macrophages (HP:0004311) | 2.41033431 |
| 47 | Protrusio acetabuli (HP:0003179) | 2.40626388 |
| 48 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.40545337 |
| 49 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.40545337 |
| 50 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.40545337 |
| 51 | Vascular tortuosity (HP:0004948) | 2.40428029 |
| 52 | Premature rupture of membranes (HP:0001788) | 2.40195981 |
| 53 | Abnormality of the intrinsic pathway (HP:0010989) | 2.37849915 |
| 54 | Disinhibition (HP:0000734) | 2.32672495 |
| 55 | Abnormality of complement system (HP:0005339) | 2.32544814 |
| 56 | Atrophic scars (HP:0001075) | 2.28675853 |
| 57 | Mitral valve prolapse (HP:0001634) | 2.27004058 |
| 58 | Abnormal platelet volume (HP:0011876) | 2.24573601 |
| 59 | Hyperglycinuria (HP:0003108) | 2.22676505 |
| 60 | Nuclear cataract (HP:0100018) | 2.20497772 |
| 61 | Back pain (HP:0003418) | 2.20341383 |
| 62 | Ankyloglossia (HP:0010296) | 2.19199967 |
| 63 | Shallow orbits (HP:0000586) | 2.15957855 |
| 64 | Aortic aneurysm (HP:0004942) | 2.15216550 |
| 65 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.14220074 |
| 66 | Abnormality of glycine metabolism (HP:0010895) | 2.14220074 |
| 67 | Abnormal cartilage morphology (HP:0002763) | 2.12987458 |
| 68 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.12175582 |
| 69 | Peritonitis (HP:0002586) | 2.11483067 |
| 70 | Flat acetabular roof (HP:0003180) | 2.11297098 |
| 71 | Hypoglycemic coma (HP:0001325) | 2.10856856 |
| 72 | Joint hemorrhage (HP:0005261) | 2.10728140 |
| 73 | Aneurysm (HP:0002617) | 2.10285233 |
| 74 | Fat malabsorption (HP:0002630) | 2.09431459 |
| 75 | Asymmetric septal hypertrophy (HP:0001670) | 2.08697811 |
| 76 | Absent frontal sinuses (HP:0002688) | 2.08543513 |
| 77 | Hyperammonemia (HP:0001987) | 2.08327961 |
| 78 | Insidious onset (HP:0003587) | 2.08305778 |
| 79 | Termporal pattern (HP:0011008) | 2.08305778 |
| 80 | Abnormality of oral frenula (HP:0000190) | 2.06882102 |
| 81 | Ankle contracture (HP:0006466) | 2.06446146 |
| 82 | Hypochromic microcytic anemia (HP:0004840) | 2.04332441 |
| 83 | Wormian bones (HP:0002645) | 2.02943190 |
| 84 | Ulnar bowing (HP:0003031) | 2.01874377 |
| 85 | Increased density of long bones (HP:0006392) | 2.00340802 |
| 86 | Bone pain (HP:0002653) | 2.00062872 |
| 87 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.99158611 |
| 88 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.98460134 |
| 89 | Pseudobulbar signs (HP:0002200) | 1.97706495 |
| 90 | Hypercholesterolemia (HP:0003124) | 1.97420078 |
| 91 | Blue sclerae (HP:0000592) | 1.96006864 |
| 92 | Biliary tract neoplasm (HP:0100574) | 1.94110884 |
| 93 | Abnormality of the Achilles tendon (HP:0005109) | 1.93771799 |
| 94 | Eczematoid dermatitis (HP:0000976) | 1.93508531 |
| 95 | Natal tooth (HP:0000695) | 1.93105496 |
| 96 | Upper motor neuron abnormality (HP:0002127) | 1.92771379 |
| 97 | Hematochezia (HP:0002573) | 1.92044239 |
| 98 | Relative macrocephaly (HP:0004482) | 1.91848929 |
| 99 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.91309940 |
| 100 | Increased connective tissue (HP:0009025) | 1.90979557 |
| 101 | Acanthocytosis (HP:0001927) | 1.90414453 |
| 102 | Cortical dysplasia (HP:0002539) | 1.89347906 |
| 103 | Abnormality of nucleobase metabolism (HP:0010932) | 1.87256867 |
| 104 | Apathy (HP:0000741) | 1.87238704 |
| 105 | Thoracolumbar scoliosis (HP:0002944) | 1.86527065 |
| 106 | Autoimmune thrombocytopenia (HP:0001973) | 1.85827811 |
| 107 | Abnormality of methionine metabolism (HP:0010901) | 1.85814109 |
| 108 | Gout (HP:0001997) | 1.84904967 |
| 109 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.84464771 |
| 110 | Hyperglycemia (HP:0003074) | 1.83695840 |
| 111 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.81728117 |
| 112 | Abnormality of purine metabolism (HP:0004352) | 1.81305996 |
| 113 | Mitral stenosis (HP:0001718) | 1.80622535 |
| 114 | Rectal prolapse (HP:0002035) | 1.80504279 |
| 115 | Fragile skin (HP:0001030) | 1.79797732 |
| 116 | Enlarged penis (HP:0000040) | 1.79364441 |
| 117 | Skin nodule (HP:0200036) | 1.78104798 |
| 118 | Cervical subluxation (HP:0003308) | 1.77022665 |
| 119 | Coarse hair (HP:0002208) | 1.76067978 |
| 120 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.75399881 |
| 121 | Elbow flexion contracture (HP:0002987) | 1.74898576 |
| 122 | Metaphyseal irregularity (HP:0003025) | 1.74834801 |
| 123 | Distal lower limb amyotrophy (HP:0008944) | 1.74737219 |
| 124 | Diminished motivation (HP:0000745) | 1.74339601 |
| 125 | Cardiovascular calcification (HP:0011915) | 1.74070340 |
| 126 | Femoral bowing (HP:0002980) | 1.73666585 |
| 127 | Dilatation of the ascending aorta (HP:0005111) | 1.73619931 |
| 128 | Hydroxyprolinuria (HP:0003080) | 1.71351604 |
| 129 | Abnormality of proline metabolism (HP:0010907) | 1.71351604 |
| 130 | Overgrowth (HP:0001548) | 1.71212138 |
| 131 | Asymmetry of the thorax (HP:0001555) | 1.70837748 |
| 132 | Thick nail (HP:0001805) | 1.70133732 |
| 133 | Pathologic fracture (HP:0002756) | 1.67817935 |
| 134 | Ovoid vertebral bodies (HP:0003300) | 1.66573463 |
| 135 | Mitral regurgitation (HP:0001653) | 1.66246537 |
| 136 | Deviation of the thumb (HP:0009603) | 1.65848412 |
| 137 | Hyperacusis (HP:0010780) | 1.65773935 |
| 138 | Recurrent bacterial skin infections (HP:0005406) | 1.65219872 |
| 139 | Genu recurvatum (HP:0002816) | 1.63993030 |
| 140 | Abnormality of the acetabulum (HP:0003170) | 1.63975635 |
| 141 | Macroorchidism (HP:0000053) | 1.62643721 |
| 142 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.62444450 |
| 143 | Lymphangioma (HP:0100764) | 1.62244653 |
| 144 | Persistence of primary teeth (HP:0006335) | 1.61863431 |
| 145 | Abnormality of the lumbar spine (HP:0100712) | 1.61724677 |
| 146 | Spinal rigidity (HP:0003306) | 1.61685345 |
| 147 | Heterotopia (HP:0002282) | 1.61585074 |
| 148 | Deep philtrum (HP:0002002) | 1.61295343 |
| 149 | Conjunctival telangiectasia (HP:0000524) | 1.61129897 |
| 150 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.60864785 |
| 151 | Polycythemia (HP:0001901) | 1.60214061 |
| 152 | Alopecia of scalp (HP:0002293) | 1.59898918 |
| 153 | Abnormality of the fingertips (HP:0001211) | 1.59798882 |
| 154 | Long toe (HP:0010511) | 1.59797615 |
| 155 | Achilles tendon contracture (HP:0001771) | 1.58701845 |
| 156 | Abnormal foot bone ossification (HP:0010675) | 1.58613353 |
| 157 | Gingival bleeding (HP:0000225) | 1.58259109 |
| 158 | Aortic dissection (HP:0002647) | 1.58039137 |
| 159 | Menorrhagia (HP:0000132) | 1.57778582 |
| 160 | Vascular calcification (HP:0004934) | 1.57343548 |
| 161 | Abnormal delivery (HP:0001787) | 1.57305659 |
| 162 | Focal segmental glomerulosclerosis (HP:0000097) | 1.56830196 |
| 163 | Follicular hyperkeratosis (HP:0007502) | 1.55972683 |
| 164 | Axonal loss (HP:0003447) | 1.55455175 |
| 165 | Abnormal biliary tract morphology (HP:0012440) | 1.55215727 |
| 166 | Right ventricular cardiomyopathy (HP:0011663) | 1.54757768 |
| 167 | Hemorrhage of the eye (HP:0011885) | 1.54640049 |
| 168 | Vertebral clefting (HP:0008428) | 1.53996102 |
| 169 | Spontaneous abortion (HP:0005268) | 1.53377058 |
| 170 | Ketosis (HP:0001946) | 1.53244012 |
| 171 | Abnormality of the calcaneus (HP:0008364) | 1.52605320 |
| 172 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.52369693 |
| 173 | Interstitial pulmonary disease (HP:0006530) | 1.50464890 |
| 174 | Global brain atrophy (HP:0002283) | 1.49316845 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 6.11749445 |
| 2 | LATS1 | 3.84250388 |
| 3 | TRIB3 | 3.46134434 |
| 4 | PKN2 | 3.36810165 |
| 5 | MAP3K14 | 2.94921388 |
| 6 | CDK12 | 2.92642015 |
| 7 | EEF2K | 2.63447284 |
| 8 | FRK | 2.39204794 |
| 9 | SIK1 | 2.29650810 |
| 10 | EPHA2 | 2.26938803 |
| 11 | STK24 | 2.16485600 |
| 12 | MAP3K10 | 2.13982794 |
| 13 | PRPF4B | 2.05869114 |
| 14 | STK3 | 2.02637141 |
| 15 | CDK6 | 2.01977509 |
| 16 | FGFR4 | 1.95489385 |
| 17 | TTN | 1.85365386 |
| 18 | NME2 | 1.82722076 |
| 19 | PTK6 | 1.81236685 |
| 20 | SCYL2 | 1.78560438 |
| 21 | CAMK1D | 1.77756395 |
| 22 | STK10 | 1.76143379 |
| 23 | ERN1 | 1.75709554 |
| 24 | PDGFRA | 1.63701516 |
| 25 | GRK7 | 1.60665424 |
| 26 | NEK2 | 1.60537333 |
| 27 | TAOK2 | 1.58477265 |
| 28 | BMPR2 | 1.56303301 |
| 29 | ICK | 1.50850796 |
| 30 | RIPK1 | 1.50211667 |
| 31 | MAP3K13 | 1.48511197 |
| 32 | NEK9 | 1.45004312 |
| 33 | TAOK3 | 1.43745744 |
| 34 | MST1R | 1.41692983 |
| 35 | MOS | 1.38964410 |
| 36 | FLT3 | 1.36719673 |
| 37 | CDC7 | 1.36570042 |
| 38 | MTOR | 1.32458259 |
| 39 | FGFR3 | 1.31172848 |
| 40 | CDK4 | 1.31040831 |
| 41 | FGFR2 | 1.30338606 |
| 42 | LRRK2 | 1.30056147 |
| 43 | CDC42BPA | 1.30023995 |
| 44 | LATS2 | 1.21998994 |
| 45 | RPS6KB2 | 1.19225580 |
| 46 | PDGFRB | 1.15149422 |
| 47 | MATK | 1.13601024 |
| 48 | ERBB4 | 1.12249101 |
| 49 | CAMK1G | 1.12121532 |
| 50 | RPS6KA4 | 1.03170108 |
| 51 | MAP3K8 | 1.02895532 |
| 52 | BMX | 1.02198917 |
| 53 | NEK1 | 1.02187408 |
| 54 | TBK1 | 1.01726543 |
| 55 | FGR | 1.01681768 |
| 56 | PAK2 | 1.00366053 |
| 57 | ALK | 0.98384071 |
| 58 | MAP2K3 | 0.96861461 |
| 59 | STK38L | 0.95719644 |
| 60 | ABL2 | 0.93819953 |
| 61 | DDR2 | 0.93436228 |
| 62 | MET | 0.91777062 |
| 63 | MAP3K9 | 0.90211624 |
| 64 | MAP3K3 | 0.89969230 |
| 65 | MELK | 0.86688254 |
| 66 | CLK1 | 0.84921766 |
| 67 | TTK | 0.84544000 |
| 68 | PTK2 | 0.84100977 |
| 69 | KSR2 | 0.83694410 |
| 70 | FGFR1 | 0.83282771 |
| 71 | JAK1 | 0.82186919 |
| 72 | TRPM7 | 0.79470668 |
| 73 | KSR1 | 0.78252684 |
| 74 | PAK4 | 0.78025538 |
| 75 | JAK2 | 0.77515729 |
| 76 | NUAK1 | 0.76845356 |
| 77 | JAK3 | 0.76114436 |
| 78 | EPHB1 | 0.74964094 |
| 79 | PIM1 | 0.74909322 |
| 80 | BRSK2 | 0.74320416 |
| 81 | MAP3K7 | 0.73261217 |
| 82 | MAP3K1 | 0.72544548 |
| 83 | SMG1 | 0.72450623 |
| 84 | MYLK | 0.70856775 |
| 85 | STK4 | 0.69873960 |
| 86 | EIF2AK3 | 0.69587208 |
| 87 | AKT3 | 0.69082847 |
| 88 | IRAK4 | 0.67930949 |
| 89 | AURKB | 0.66866075 |
| 90 | IRAK2 | 0.66294378 |
| 91 | RET | 0.66249821 |
| 92 | PIM2 | 0.64490664 |
| 93 | MAPK11 | 0.62982162 |
| 94 | PDK2 | 0.62208802 |
| 95 | ZAP70 | 0.61133156 |
| 96 | CHEK1 | 0.60332459 |
| 97 | TYK2 | 0.60224327 |
| 98 | MAP3K2 | 0.60104942 |
| 99 | CHUK | 0.59693173 |
| 100 | WEE1 | 0.59340759 |
| 101 | CDK9 | 0.57068771 |
| 102 | ARAF | 0.56815716 |
| 103 | TGFBR2 | 0.55139707 |
| 104 | IKBKB | 0.54988041 |
| 105 | DMPK | 0.54940929 |
| 106 | BRD4 | 0.54307568 |
| 107 | GSK3A | 0.53367484 |
| 108 | MAP3K5 | 0.51796034 |
| 109 | WNK1 | 0.51686381 |
| 110 | CSK | 0.51374722 |
| 111 | IRAK1 | 0.49981681 |
| 112 | NTRK1 | 0.49345699 |
| 113 | RPS6KA2 | 0.48902891 |
| 114 | MAP4K1 | 0.47939888 |
| 115 | SGK3 | 0.47602215 |
| 116 | ATM | 0.47481508 |
| 117 | BCKDK | 0.46236474 |
| 118 | EGFR | 0.45760986 |
| 119 | BLK | 0.44800742 |
| 120 | ABL1 | 0.43702308 |
| 121 | CSNK1D | 0.42826746 |
| 122 | MAP3K6 | 0.42240385 |
| 123 | PRKAA2 | 0.40987559 |
| 124 | PBK | 0.40907418 |
| 125 | IKBKE | 0.40859484 |
| 126 | PRKAA1 | 0.40672370 |
| 127 | AKT2 | 0.40546472 |
| 128 | PDPK1 | 0.39462066 |
| 129 | ITK | 0.38379712 |
| 130 | MAP2K1 | 0.37761467 |
| 131 | CDK7 | 0.37564515 |
| 132 | PLK3 | 0.37535818 |
| 133 | ACVR1B | 0.37532544 |
| 134 | CDK2 | 0.37380570 |
| 135 | PIK3CG | 0.37197720 |
| 136 | TAOK1 | 0.36942320 |
| 137 | DYRK1B | 0.36642806 |
| 138 | ATR | 0.36104769 |
| 139 | GRK6 | 0.34743810 |
| 140 | FER | 0.34429455 |
| 141 | RPS6KL1 | 0.33130865 |
| 142 | RPS6KC1 | 0.33130865 |
| 143 | TYRO3 | 0.32740116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.80159786 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.06540777 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.75378844 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.63101280 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.52422188 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.48485226 |
| 7 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.41470101 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.17565600 |
| 9 | Malaria_Homo sapiens_hsa05144 | 2.12459179 |
| 10 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.11157731 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 2.07848283 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.06862268 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.04178657 |
| 14 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.01482189 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.95015906 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.94862045 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.93211222 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 1.90157790 |
| 19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.82740547 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.79022127 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.77551088 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76337779 |
| 23 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.76050095 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.75675175 |
| 25 | Lysine degradation_Homo sapiens_hsa00310 | 1.75545470 |
| 26 | Salmonella infection_Homo sapiens_hsa05132 | 1.68099315 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.66454009 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.65050709 |
| 29 | Prion diseases_Homo sapiens_hsa05020 | 1.64456170 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.59772893 |
| 31 | Pertussis_Homo sapiens_hsa05133 | 1.58887048 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.47884009 |
| 33 | Leishmaniasis_Homo sapiens_hsa05140 | 1.46980307 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.45885426 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.45145479 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.41252080 |
| 37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.35617812 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.34028550 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.32401368 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.29107799 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.28055230 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.25618702 |
| 43 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.25197832 |
| 44 | Tuberculosis_Homo sapiens_hsa05152 | 1.24029377 |
| 45 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.23593713 |
| 46 | Bile secretion_Homo sapiens_hsa04976 | 1.23036278 |
| 47 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.22384304 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19837182 |
| 49 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.18267589 |
| 50 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.16387014 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.14053861 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 1.13339998 |
| 53 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.11970068 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.09764539 |
| 55 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.06283115 |
| 56 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.05493437 |
| 57 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.05190307 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.05073512 |
| 59 | Phagosome_Homo sapiens_hsa04145 | 1.04277208 |
| 60 | Adherens junction_Homo sapiens_hsa04520 | 1.03529794 |
| 61 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.02520945 |
| 62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.01875117 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.01429486 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.01382508 |
| 65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.00445413 |
| 66 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.00282345 |
| 67 | Measles_Homo sapiens_hsa05162 | 0.99768370 |
| 68 | Peroxisome_Homo sapiens_hsa04146 | 0.99733769 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.98429948 |
| 70 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.97584378 |
| 71 | Apoptosis_Homo sapiens_hsa04210 | 0.94971204 |
| 72 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.93294906 |
| 73 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.92961235 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.92238060 |
| 75 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.90625672 |
| 76 | ABC transporters_Homo sapiens_hsa02010 | 0.90543067 |
| 77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90506768 |
| 78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.88811215 |
| 79 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.87921733 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.87521381 |
| 81 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.87043327 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.86880896 |
| 83 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.86179880 |
| 84 | Histidine metabolism_Homo sapiens_hsa00340 | 0.86018599 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86000195 |
| 86 | Retinol metabolism_Homo sapiens_hsa00830 | 0.84530799 |
| 87 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.82503736 |
| 88 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.82156468 |
| 89 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.80688221 |
| 90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.80495025 |
| 91 | Bladder cancer_Homo sapiens_hsa05219 | 0.78619651 |
| 92 | Focal adhesion_Homo sapiens_hsa04510 | 0.76602636 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74719812 |
| 94 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.74093202 |
| 95 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.73987716 |
| 96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.73964025 |
| 97 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.73201834 |
| 98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73042063 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72923768 |
| 100 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.71515232 |
| 101 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70852702 |
| 102 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.70604822 |
| 103 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.69557361 |
| 104 | Amoebiasis_Homo sapiens_hsa05146 | 0.69544932 |
| 105 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.67989672 |
| 106 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.67751354 |
| 107 | Prostate cancer_Homo sapiens_hsa05215 | 0.67747779 |
| 108 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.67334262 |
| 109 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.66484769 |
| 110 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.65804736 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65144287 |
| 112 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.63940364 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.63527262 |
| 114 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.62216052 |
| 115 | Glioma_Homo sapiens_hsa05214 | 0.61705697 |
| 116 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60137446 |
| 117 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59541604 |
| 118 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59107316 |
| 119 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58878938 |
| 120 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56923665 |
| 121 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.56885696 |
| 122 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56276559 |
| 123 | Pathways in cancer_Homo sapiens_hsa05200 | 0.56089017 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55665188 |
| 125 | Melanoma_Homo sapiens_hsa05218 | 0.54155614 |
| 126 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54100676 |
| 127 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53927588 |
| 128 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53844810 |
| 129 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53549344 |
| 130 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52181902 |
| 131 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.51866227 |
| 132 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.51436969 |
| 133 | Cell cycle_Homo sapiens_hsa04110 | 0.50707683 |
| 134 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50573182 |
| 135 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.50377391 |
| 136 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.50073480 |
| 137 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50059927 |
| 138 | RNA transport_Homo sapiens_hsa03013 | 0.50011525 |
| 139 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.49335716 |
| 140 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48346107 |
| 141 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.47606114 |
| 142 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.47186692 |
| 143 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.46799704 |
| 144 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46254409 |
| 145 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.45930159 |
| 146 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.45836742 |
| 147 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44186014 |
| 148 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.43099465 |
| 149 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42690589 |
| 150 | Sulfur relay system_Homo sapiens_hsa04122 | 0.42649850 |
| 151 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42648513 |
| 152 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.41971188 |
| 153 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39644714 |
| 154 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.39435240 |
| 155 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.38759775 |
| 156 | Viral myocarditis_Homo sapiens_hsa05416 | 0.37767765 |
| 157 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37707282 |
| 158 | Hepatitis B_Homo sapiens_hsa05161 | 0.36341092 |
| 159 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36063532 |
| 160 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34228111 |
| 161 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.33487506 |
| 162 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.33221611 |

